...
首页> 外文期刊>Annals of Indian Academy of Neurology >Intrasinus thrombolysis in cerebral venous sinus thrombosis: Experience from a university hospital, India
【24h】

Intrasinus thrombolysis in cerebral venous sinus thrombosis: Experience from a university hospital, India

机译:脑静脉窦血栓形成的窦内溶栓:印度大学医院的经验

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Intrasinus thrombolysis (IST) is believed to improve outcome in patients of cerebral venous sinus thrombosis (CVST) unresponsive to heparin. Purpose: The purpose of this article is to describe our experience with IST in patients of CVST unresponsive to heparin. Materials and Methods: Hospital databases were searched, and patients with CVST who underwent IST from May 2011 to March 2014 were identified. Data on clinical presentation, duration of symptoms, and indications and dosage of IST were retrieved and outcomes analyzed. Results: Twenty-four patients received IST. The presenting symptoms included headache ( n = 19), seizures ( n = 16), and altered sensorium ( n = 14); signs included papilledema ( n = 20) and hemiparesis ( n = 15). Nineteen patients received unfractionated heparin (UFH), four received low-molecular-weight heparin (LMWH), and one received both. In one patient, microcatheter could not be passed, two patients bled intracranially, and three had nonintracranial bleeds. Among four deaths, none was due to iatrogenic bleeding. On discharge, 10 patients (43.5%) had good improvement with the modified Rankin Scale (score; mRS) ≤2 and eight (34.8%) had partial improvement with mRS = 3, 4. Seventeen patients (73.9%) had mRS ≤2 at 6 months follow-up. Bleeding complications of urokinase were less than those of alteplase. Recanalization of the involved sinuses was achieved in all. Early intervention led to successful recanalization. Functional recanalization decreased intracranial bleeding. Conclusion: Till date, our study is the largest series of IST in CVST reported from India. IST may be more effective than systemic heparin anticoagulation in moribund and unresponsive patients despite the potential for bleeding manifestations. Functional recanalization is adequate for good results. However, a randomized prospective study comparing heparin anticoagulation with IST is warranted.
机译:背景:窦内溶栓(IST)被认为可改善对肝素无反应的脑静脉窦血栓形成(CVST)患者的预后。目的:本文的目的是描述我们在对肝素无反应的CVST患者中使用IST的经验。资料和方法:检索医院数据库,确定2011年5月至2014年3月接受IST治疗的CVST患者。检索有关临床表现,症状持续时间,IST适应症和剂量的数据,并分析结果。结果:二十四例患者接受了IST。出现的症状包括头痛(n = 19),癫痫发作(n = 16)和感觉觉改变(n = 14)。体征包括乳头水肿(n = 20)和偏瘫(n = 15)。 19例接受普通肝素(UFH),4例接受低分子量肝素(LMWH),1例同时接受。一名患者无法通过微导管,两名患者颅内出血,三名非颅内出血。在四例死亡中,没有一例是由于医源性出血引起的。出院时,改良Rankin量表(评分; mRS)≤2改善了10例患者(43.5%),mRS = 3、4改善了8例(34.8%)。mRS≤2有17例患者(73.9%)得到了改善。在6个月的随访中。尿激酶的出血并发症少于阿替普酶。涉及窦的再通气全部实现。早期干预导致成功的再通。功能性再通减少颅内出血。结论:到目前为止,我们的研究是印度报道的CVST中最大的IST系列。尽管可能有出血表现,但在垂死和无反应的患者中,IST可能比全身肝素抗凝治疗更有效。功能性再通气足以获得良好结果。但是,有必要进行一项比较肝素抗凝治疗与IST的随机前瞻性研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号